Matches in Nanopublications for { ?s ?p "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP644682.RAl5_jItY80Yhw2POGhYfXzJsa7Qr5FqyA-gkgnt93p0o130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644682.RAl5_jItY80Yhw2POGhYfXzJsa7Qr5FqyA-gkgnt93p0o130_provenance.
- NP661082.RAVnFzCkE103EG3JPpF13VrDP6nxLQDt5VlwTQZyjaOKM130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661082.RAVnFzCkE103EG3JPpF13VrDP6nxLQDt5VlwTQZyjaOKM130_provenance.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_provenance.
- NP486160.RAoHUznDuL32lem_NuV_Gyn9ZDhSgu7Kt7-iPxmic13as130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486160.RAoHUznDuL32lem_NuV_Gyn9ZDhSgu7Kt7-iPxmic13as130_provenance.
- NP663919.RAkl_C4puuEojGWb4ucRFOm9knHlENRlVsw9PjPIQ1Cc8130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663919.RAkl_C4puuEojGWb4ucRFOm9knHlENRlVsw9PjPIQ1Cc8130_provenance.
- NP888837.RARA_A3nrR55w65ktArc_TVbZ1LXdoiC4Ue_NxQcfbg_g130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888837.RARA_A3nrR55w65ktArc_TVbZ1LXdoiC4Ue_NxQcfbg_g130_provenance.
- NP804641.RAjKpmDlMXnzQHFmoIY1CT2BcqnYkiJqhrE_d1fKzBsbs130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804641.RAjKpmDlMXnzQHFmoIY1CT2BcqnYkiJqhrE_d1fKzBsbs130_provenance.
- NP718664.RAaRpSBU_qnT-_BpV4cXlALGMZJBGUKyUr_MTwZnkAbOQ130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718664.RAaRpSBU_qnT-_BpV4cXlALGMZJBGUKyUr_MTwZnkAbOQ130_provenance.
- NP240969.RA30sau31VAEMD2h5FOwEPUa6dUgi0zzLhg54m7J8yhT8130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240969.RA30sau31VAEMD2h5FOwEPUa6dUgi0zzLhg54m7J8yhT8130_provenance.
- NP880968.RAwTV8ts2kpFjEiBcJDBA2NxENvNO1nbkt4JhiB1-9BYo130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880968.RAwTV8ts2kpFjEiBcJDBA2NxENvNO1nbkt4JhiB1-9BYo130_provenance.
- NP889308.RA8ExilKjkO17gvErCJnvasd4t2iCGzihHrAmG7vQ_ydw130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889308.RA8ExilKjkO17gvErCJnvasd4t2iCGzihHrAmG7vQ_ydw130_provenance.
- NP912401.RAP1EzWs3NLMnNUdyAySaF8m8VKdg3NxEGi7BjgcM0l5c130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912401.RAP1EzWs3NLMnNUdyAySaF8m8VKdg3NxEGi7BjgcM0l5c130_provenance.
- NP912746.RANeCLgvP8HssTvyL7yIdbkUjqbtDY0dXwG42HKIvcxJI130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912746.RANeCLgvP8HssTvyL7yIdbkUjqbtDY0dXwG42HKIvcxJI130_provenance.